Neuroimmunometabolism
30 min
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Clinical Introduction
-
49 min
1. Frontotemporal dementia- Prof. Bruce Miller
-
40 min
2. Huntington's disease- Prof. Roger Barker
- Neuroimaging
-
22 min
3. Molecular brain imaging (PET) in diseases with dementia- Prof. Emeritus Karl Herholz
- Pathology, Genetic and Molecular Aspects (1)
-
21 min
-
42 min
5. A molecular understanding of Alzheimer's disease- Prof. John Hardy
-
33 min
6. Neuropathology of neurodegenerative disorders- Prof. Jillian Kril
-
52 min
- Pathology, Genetic and Molecular Aspects (2)
-
46 min
8. The molecular biology of Huntington's disease- Prof. David C. Rubinsztein
-
46 min
9. Metals, oxidative stress and neurodegeneration- Prof. Ashley Bush
- Latest Developments in the Field
-
46 min
10. Animal models of tauopathy- Prof. David Westaway
-
61 min
11. Parkinson's disease and transplants- Prof. Roger Barker
- Archived Lectures *These may not cover the latest advances in the field
-
29 min
12. Neuropathology of neurodegenerative disorders- Prof. Jillian Kril
-
36 min
13. Motor neurone disease: molecular basis- Prof. Kevin Talbot
-
51 min
14. Alzheimer's disease (AD)- Prof. John Hodges
-
53 min
15. Frontotemporal dementia syndromes- Prof. John Hodges
-
38 min
16. Motor neurone disease: clinical aspects- Prof. Kevin Talbot
-
26 min
17. Neuro-imaging in dementia: using MRI in routine work-up- Prof. Philip Scheltens
-
53 min
18. Prion diseases- Prof. Pierluigi Gambetti
-
38 min
19. Mitochondrial disorders and neurodegeneration- Prof. Anthony Schapira
-
44 min
20. Mutations in parkinsonian syndromes- Dr. Andrew Singleton
-
42 min
-
32 min
22. Frontotemporal dementia- Prof. Bruce Miller
-
57 min
23. Parkinson disease- Prof. Stanley Fahn
-
12 min
24. Ubiquitination and Alzheimer related disorders- Prof. John Mayer
-
35 min
25. Atypical parkinsonian syndromes- Dr. David Burn
Printable Handouts
Navigable Slide Index
- Intro slide
- Scope of the presentation
- Progressive supranuclear pulsy
- Charles Dickens and PSP?
- Descriptive epidemiology of PSP
- The "typical" PSP case
- Clinical features
- Falls in PSP vs. Parkinson's disease
- Cognitive and behavioural changes
- NINDS-SPSP criteria (1996)
- Atypical clinical features in PSP
- Natural history of PSP
- Pathology of PSP
- PSP: clinical and genetic correlation
- Recent drug studies in PSP I
- Recent drug studies in PSP II
- Multiple system atrophy
- Descriptive epidemiology of MSA
- MSA: clinicopathological features
- Motor features of MSA
- Autonomic failure in MSA
- MSA and cognitive impairment
- Quinn diagnostic criteria (1994)
- When to suspect MSA
- Physical signs in MSA
- Natural history of MSA
- Management of parkinsonism in MSA
- Management of autonomic failure in MSA I
- Management of autonomic failure in MSA II
- Corticobasal degeneration
- General features of CBD
- CBD: diagnostic features
- Investigations of atypical parkinsonian disorders
- Structural MRI in PSP and MSA
- VBM in PSP: grey matter loss
- MR spectroscopy in PSP
- Functional imaging (PET & SPECT)
- 18F-dopa PET in parkinsonism
- Sphincter EMG and parkinsonism
- Future therapeutic directions
- Conclusion
Topics Covered
- Types of atypical parkinsonian syndromes
- Descriptive epidemiology
- Clinical features
- Cognitive and neurobehavioural aspects
- Pathology and aetiology
- Natural history
- Structural and functional investigations
- Clinical management
- Future research directions
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Burn, D. (2007, October 1). Atypical parkinsonian syndromes [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 25, 2025, from https://doi.org/10.69645/KOIE6457.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. David Burn has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
